Nyxoah Overview

  • Founded
  • 2009
Founded
  • Status
  • Public
  • Employees
  • 42
Employees
  • Stock Symbol
  • NYXH
Stock Symbol
  • Share Price
  • $17.90
  • (As of Monday Closing)

Nyxoah General Information

Description

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Contact Information

Website
www.nyxoah.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Stock Exchange
BRU
Primary Office
  • Rue Edouard Belin 12
  • 1435 Mont-Saint-Guibert
  • Belgium
+32 010 00 00 00

Nyxoah Timeline

2019202020212022
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nyxoah Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$17.90 $18.79 $16.64 - $35.59 $485M 25.8M 4.34K -$1.11

Nyxoah Financials Summary

In Thousands,
USD 		TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 582,629 390,464
Revenue 505 79 0 0
EBITDA (22,026) (12,923) (8,854) (10,520)
Net Income (24,501) (13,958) (9,464) (10,714)
Total Assets 129,011 140,315 17,021 20,566
Total Debt 14,090 14,194 9,632 6,652
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Nyxoah Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nyxoah‘s full profile, request access.

Request a free trial

Nyxoah Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion
Price		 % Owned

This information is available in the PitchBook Platform. To explore Nyxoah‘s full profile, request access.

Request a free trial

Nyxoah Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to t
Therapeutic Devices
Mont-Saint-Guibert, Belgium
42 As of 2020
00000
0000 0000-00-00
00000000 00000

0000000

dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut ali
00000000000 0000000
Zhubei, Taiwan
00 As of 0000
00000000

00000000

gna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea
00000000000 0000000
Minnetonka, MN
00 As of 0000
00000
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nyxoah Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Somnics Formerly VC-backed Zhubei, Taiwan 00 00000000
00000000000 Formerly VC-backed Minnetonka, MN 00 00000 000000&0 00000
000000 Venture Capital-Backed Arden Hills, MN 00 000.00 00000000000 000.00
000000000 00000000 Private Equity-Backed Somerset, PA 000 000 000000000000 000
0000000 0000000 00 Formerly VC-backed Maple Grove, MN 000 00000 00000000 00000
You’re viewing 5 of 9 competitors. Get the full list »

Nyxoah Patents

  • 323

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 13

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

Nyxoah Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2018227019-A1 Surgical implant system Pending 28-Feb-2017 0000000000
CA-3054180-A1 Surgical implant system Pending 28-Feb-2017 0000000000
JP-2020508759-A Surgical implant system Pending 28-Feb-2017 0000000000
EP-3589358-A1 Surgical implant system Pending 28-Feb-2017 0000000000
US-20200001082-A1 Surgical implant system Pending 28-Feb-2017 A61N1/3611
To view Nyxoah’s complete patent history, request access »

Nyxoah Executive Team (12)

Name Title Board Seat Contact Info
Olivier Taelman Chief Executive Officer & Board Member
Loic Moreau Chief Financial Officer
Fabian Gonzalez Chief Financial Officer, Finance
Remi Renard Vice President, Therapy Development
Claudio Vicini Ph.D Scientific Advisor
You’re viewing 5 of 12 executive team members. Get the full list »

Nyxoah Board Members (12)

Name Representing Role Since
Christopher Smith Self Board Member 000 0000
Don Deyo Self Board Member 000 0000
Jan Janssen Cochlear Board Member 000 0000
Janke Dittmer Ph.D Gilde Healthcare Partners Board Member 000 0000
Jurgen Hambrecht Ph.D Nyxoah Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Nyxoah Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nyxoah Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Nyxoah‘s full profile, request access.

Request a free trial